Skip Navigation


Annals of Oncology Advance Access originally published online on April 20, 2006
Annals of Oncology 2006 17(6):885-887; doi:10.1093/annonc/mdl073
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
17/6/885    most recent
mdl073v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cherny, N. I.
Right arrow Articles by Kosmidis, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cherny, N. I.
Right arrow Articles by Kosmidis, P. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2006 European Society for Medical Oncology

editorial

Problems of opioid availability and accessibility across Europe: ESMO tackles the regulatory causes of intolerable and needless suffering

N. I. Cherny1,*, R. Catane2 and P. A. Kosmidis3,4

1 Shaare Zedek Medical Center, Medical Oncology, Jerusalem; 2 Sheba Medical Center, Oncology, Tel Aviv, Israel; 3 Hygeia Hospital, Oncology, Athens, Greece; 4 European Society of Medical Oncology, Past President, Lugano, Switzerland

* E-mail: chernyn@netvision.net.il

The first 10% of the full text of this article appears below.

The bare minimum that one can do for a patient with advanced and incurable cancer is to ensure that pain is adequately relieved. Sadly, many patients in Europe do not receive this minimum of treatment. Whereas some of the western European countries have regulations that make opioids widely available at minimal cost to patients in need, for a great many others availability and accessibility are severely hampered by either restrictive laws and regulations or, at times, by the lack of affordable formulations.

It is widely recognized that there . . . [Full Text of this Article]

problems of availability and accessibility

eastern Europe as a specific problem

ESMO and advocacy

appendix


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur J Heart FailHome page
T. Jaarsma, J. M. Beattie, M. Ryder, F. H. Rutten, T. McDonagh, P. Mohacsi, S. A. Murray, T. Grodzicki, I. Bergh, M. Metra, et al.
Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology
Eur J Heart Fail, May 1, 2009; 11(5): 433 - 443.
[Abstract] [Full Text] [PDF]

Home page
 Am Soc Clin Oncol Ed BookHome page
J. H. Von Roenn, F. Strasser, and C. F. von Gunten
Update on the Integration of Palliative Care into Cancer Care
ASCO Educational Book, January 1, 2009; 2009(1): 590 - 596.
[Abstract] [Full Text] [PDF]